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The  present  study  compares  the  proﬁle  of  NK cells  in  an  in  vitro  re-exposure  by  Vaccinia  virus  (VACV),
in  groups  that  have  had  a previous  vaccination  or natural  infection.  Our  data  suggests  that  stimulation
with  VACV  triggers  a cytotoxic  response  by  NK  cells  marked  by an  increase  of NCRs:  NKp30,  NKp44,
and  NKp46  in  infected  (vaccinated  and  unvaccinated)  subjects  and  in  non-infected  vaccinated  patients,
when  compared  with  non-infected  unvaccinated  individuals.  However,  the  degranulation  and  secre-
tion processes  are  inhibited  in  infected  (vaccinated  and  unvaccinated)  subjects  and  in  the  non-infected
vaccinated  patients,  when  compared  with  non-infected  unvaccinated  individuals.  We  demonstrated  that
stimulation with  VACV  downregulates  the  percentage  of expression  of  Perforin,  Granzyme  A, and  CD107a,
but upregulate  CD94  in infected  (vaccinated  and  unvaccinated)  subjects  and  in non-infected  vaccinated
patients,  when  compared  with  non-infected  unvaccinated  individuals.  Furthermore,  the percentage  of
IFN-+ NK  cells  was  signiﬁcantly  lower  in  non-infected  unvaccinated  subjects,  when compared  with
infected  (vaccinated  and  unvaccinated)  and  non-infected  vaccinated  individuals.  Our  results  also  show
that the  percentage  of TNF-+ NK cells  was  signiﬁcantly  higher  in infected  (vaccinated  and  unvaccinated)
subjects  and  in  non-infected  vaccinated  patients,  when  compared  with non-infected  unvaccinated  indi-
viduals,  after in vitro  stimulation  with  UV-inactivated  VACV.  Our  data  suggest  that  the  expression  of  NCRs
NKp30, NKp44,  NKp46  and  cytokines  by NK  cells are important  in  the  innate  response  against  VACV.. Introduction
Vaccinia virus (VACV) is the causative agent of a zoonotic infec-
ion that affects cattle and humans in many regions of Brazil and
ince 1969, VACV outbreaks have been reported in different regions
f the country (Medeiros-Silva et al., 2010). Despite the fact that the
umber of human cases is still increasing and new epidemic foci
ave been reported, little is known about the human immunologi-
al response against VACV natural infection, but it is clear that both
he innate and adaptative responses are important (Lewis-Jones,
004).
Natural killer (NK) cells constitutes an important element of the
nnate immune response against Poxvirus (Bukowski et al., 1983;
∗ Corresponding author at: Universidade Federal de Minas Gerais, Departamento
e Bioquimíca e Imunologia, Av. Antônio Carlos 6627, Pampulha, Caixa Postal 486,
EP: 31270-901, Belo Horizonte, MG,  Brazil. Tel.: +55 31 88079591.
E-mail address: duduaugusto1@yahoo.com.br (E.A.d.S. Moreira-Silva).
ttp://dx.doi.org/10.1016/j.virusres.2014.02.001
168-1702/© 2014 Elsevier B.V. All rights reserved.© 2014  Elsevier  B.V.  All  rights  reserved.
Stitz et al., 1986). It has been described that VACV infection induces
activation, proliferation, and accumulation of NK cells at the site
of infection (Bukowski et al., 1983; Daniels et al., 2001; Dokun
et al., 2001; Natuk and Welsh, 1987). It has been demonstrated that
infection with Orthopoxvirus induces a marked increase in the sus-
ceptibility of target cells to lysis by NK cells and it seems that the
natural cytotoxicity receptors NKp30, NKp44, and NKp46 are the
most important NK cell receptors for the recognition of the VACV-
infected target cell (Chisholm and Reyburn, 2006). Other NK cell
receptors are well known to be involved in the immune response
against Poxvirus. Among them are the surface molecules, CD161,
that is involved in the inhibition process and is one of the earli-
est markers of NK cells (Rosen et al., 2005; Aldemir et al., 2005;
Germain et al., 2011) and CD94 that has an essential role in the
resistance of B6 mice to Mousepoxvirus (Fang et al., 2011).Several new families of activators and inhibitory receptors have
been recently identiﬁed on NK cells that have their activity deter-
mined by the balance of the expression of these receptors (Konjevic´
et al., 2009). Although this has been shown to be critical there are no
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tudies that evaluate the role of the different receptors expressed
y NK cells against Vaccinia virus in human infection. In the present
tudy, we evaluated the phenotype of NK cells expressing inhibitory
arkers (CD161), activation markers (CD94), natural cytotoxicity
eceptors (NKp30, NKp44, and NKp46), cytokines (IFN- and TNF-
), Granzymes (Granzyme A and B) and Perforins, after in vitro
timulation with UV-inactivated VACV following a natural Vaccinia
irus infection after a zoonotic outbreak that occurred in Brazil in
005.
. Patients, materials, and methods
.1. Study population
In 2005, a zoonotic outbreak of Vaccinia virus infection occurred
n different areas in the state of Minas Gerais in Brazil. During the
utbreak, blood from the affected individuals and from the cattle
ere collected and sent to Laboratory of Virus of the Universidade
ederal de Minas Gerais (UFMG) and to the Immunology Labo-
atory in the Centro de Pesquisas Rene Rachou, FIOCRUZ-Minas
o conﬁrm the infection by VACV. As an extension of the studies
uring the outbreak, this investigation was initiated to evaluate
he immune responses 5 year post exposure. The same individ-
als were recruited by our research group and blood collected at
he 5-year time point to investigate the NK cells phenotype after
n vitro stimulation with the virus. A total of 42 individuals were
ncluded in this study (Table 1). Out of the 42 individuals, 22 were
reviously infected by VACV and 20 were not affected by the dis-
ase. Important to note that out of the 22 infected individuals,
2 were vaccinated against smallpox and 10 were unvaccinated.
ut of the 20 non-infected individuals, 10 were previously vac-
inated and 10 were normal healthy individuals unvaccinated
negative control). Infections and/or vaccinations were conﬁrmed
ith Plaque-reduction neutralization tests and/or IgG ELISA tests.
accinated individuals were identiﬁed by their vaccination card
nd/or vaccination scar. All study participants provided written
nformed consent following the guidelines of the Human Research
thics Committee of the Universidade Federal de Minas Gerais.
.2. Viruses and cells
Vero cells were used for virus replication, titration and UV
nactivated viral test (Campos and Kroon, 1993). A thin layer of viral
tocks, at a distance of 15 cm,  were exposed 5 to 10 min  to UV radi-
tion at a wavelength of 280 nm.  UV irradiated viruses were then
ested for virus infectivity. Viruses that were unable to form plaques
ere considered to be UV inactivated. The infectious and cyto-
athic nature of VACV live virus limits its use in some applications,
ecause it causes the host cell’s death. UV inactivated VACV were
sed because it has been demonstrated that treatment of VACV
ith UV light results in the inactivation of viral replication without
he abolition of viral transcription under early viral promoters. Fur-
hermore, the antigenicity of the UV-inactivated VACV was found
ndistinguishable from that of the replicating VACV, both for res-
imulating the VV-primed cytotoxic T lymphocytes and serving as
he cytotoxic T-lymphocyte target in vitro (Tsung et al., 1996). The
ytopathic effect (CPE) of infection with VACV in particular includes
he induction of early cell rounding, damage to the host genome and
NA, inhibition of host protein synthesis, and eventually, death of
he infected cells (Bablanian, 1975)..3. Cell phenotype analysis
In vitro short-term cultures of whole blood samples were
erformed. Whole blood cells were stimulated in vitro withResearch 184 (2014) 20–29 21
UV-inactivated VACV in RPMI 1640 media for 6 h at 37 ◦C. Approx-
imately 1 × 104 PFU of Vaccinia virus strain WR were added per
1 × 106 leukocytes. Control cultures were maintained in cul-
ture media for the same period of time. Cultured cells were
washed in FACS buffer and stained with monoclonal antibodies
against CD3 (FITC, BD-Pharmingen, clone HIT3a), CD16 (PerCp,
EXBIO, clone LNK16) and CD56 (APC, BD-Pharmingen, clone
B159). The same cells were labeled simultaneously with anti-
bodies against CD94 (PE, BD-Pharmingen, clone HP-3D9), CD107a
(PE, BD-Pharmingen, clone H4A3), NKp30 (PE, BD-Pharmingen,
clone P30-15), NKp44 (PE, BD-Pharmingen, clone P44-8.1), NKp46
(PE, BD-Pharmingen, clone 9E2/Nkp46). Cell preparations were
ﬁxed in FACS ﬁx solution and stored at 4 ◦C in the dark. A total
of 100,000 events/tube were acquired using a FACScalibur ﬂow
cytometer (Becton Dickinson). CELLQuestTM software was used
for data acquisition and the FLOW JO Version 7.5.5 software for
analysis.
2.4. Intracellular cytokine staining (ICCS)
Whole blood was  stimulated in vitro with UV-inactivated VACV
as described above. During the last 4 h of culture, Brefeldin A was
added. Cultured cells were washed twice in FACS buffer and stained
with monoclonal antibodies speciﬁc for the different cell-surface
markers, as described above. The cells were then permeabilized in
saponin buffer and stained intracellularly with monoclonal anti-
bodies against IFN- (PE, BD-Pharmingen, clone 4S.B3), TNF- (PE,
BD-Pharmingen, clone 6401.1111), Perforin (PE, BD-Pharmingen,
clone G9), Granzyme A (PE, BD-Pharmingen, clone CB9) and
Granzyme B (PE, BD-Pharmingen, clone GB11). A total of 100,000
events/tube were acquired using a FACScalibur ﬂow cytometer (BD
Biosciences, USA). The samples were analyzed by using FlowJo soft-
ware (Tree Star—Version 7.5.5).
2.5. FACS analysis of surface markers and intracellular cytokine
NK cells were analyzed for their intracellular cytokine expres-
sion patterns and frequencies as well as for cell surface markers
using the FlowJo software (Tree Star—Version 7.5.5), as described
in Supplementary Fig. 1. (A) First we  performed the identiﬁca-
tion of peripheral lymphocytes population in diagram of FSC × SSC
(R1) (Fig. S1A). Second we made dot plots of FSC × FL-1, display-
ing the frequency of CD3+ and CD3− cells. Thus, CD3− cells were
selected (R2) (Fig. S1B). Third, dot plots of FL-3 × FL-4 were made
displaying the frequency of CD3−CD16−CD56+, CD3−CD16+CD56−,
CD3−CD16+CD56+ populations (R3) (Fig. S1C). Finally, we made
dot plots of FSC × FL-2, displaying the frequency of NK cells, co-
expressing the marker CD107a (R4) (Fig. S1D). The same strategy
was used to select the frequency of NK cells, co-expressing NKp30,
NKp44, NKp46, CD161, CD94, IFN-, TNF-, Granzyme A, Granzyme
B and Perforin (R4) (ﬁgure not shown). Limits for the quadrant
markers were always set based on negative populations and isotype
controls.
2.6. Statistical analysis
Analyses were performed using GraphPad Prism version
4.0 software (GraphPad Software Inc, USA). The nonparametric
Mann–Whitney U test was  performed to compare stimulated and
non-stimulated cultures in each of the four groups. Kruskal–Wallis
test was  used to compare the four clinical groups, followed
by Dunn’s test to compare all pairs of experiments. Differences
were considered signiﬁcant when the p value was less than
0.05.
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Table  1
Characterization of the population involved in the study.
Groups Vaccination status Number of individuals studied Mean age (min–max) Gender (n)
Male Female
Previously infected* Vaccinated** 12 56 (42–68) 12 0
Unvaccinated 10 24.5 (18–34) 10 0
Noninfected Vaccinated*** 10 46.4 (39–62) 7 3
Unvaccinated 10 29.2 (28–31) 6 4
* These individuals were infected with Vaccinia virus during outbreaks that occurred in 2005 in different farms in the state of Minas Gerais, Brazil.
** Importantly, out of 22 individuals previously infected, 12 were vaccinated against smallpox in the past, as conﬁrmed by visualization of a typical vaccination scar in their
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marker by NK cells has also been shown to have inhibitory activ-
ity (Rosen et al., 2005; Aldemir et al., 2005; Germain et al., 2011).
Our results showed an increase on the percentage of NK cells co-
expressing CD161 in the infected (vaccinated and unvaccinated)
Table 2
Mean percentage of NK cells on the whole blood from individuals infected (vacci-
nated and unvaccinated) and noninfected (vaccinated and unvaccinated) by Vaccinia
virus after in vitro stimulation with UV-inactivated VACV.
Groups NK cells/std. deviation
Noninfected Unvaccinated 30.52 ± 4.87
Vaccinated 35.26 ± 8.89eft  arm.
*** Of the 20 individuals noninfected, 10 were vaccinated against smallpox in the p
rom  vaccination card.
. Results
.1. Previous vaccination against smallpox leads to a milder form
f VACV infection
In this study some infected individual were previously vac-
inated against smallpox. Despite their vaccination status they
cquired VACV infection. In order to evaluate the clinical differ-
nces between vaccinated and unvaccinated infected individuals
as previously validated by a questionnaire applied to all vol-
nteers. It was observed that the mean age was 24.5 years in
nvaccinated individuals and 56 years in the vaccinated group. All
ubjects studied were male, milkers and the average of time worked
n this function was 18 years among the unvaccinated individuals
nd 32 years in the vaccinated group. None of these individuals
eported having a prior infection by VACV. It was  observed that
he number and type of symptoms (fever, generalized pain, lym-
hadenopathy, headache, and others) presented by unvaccinated
nd vaccinated individuals were signiﬁcantly different. The average
f symptoms was of 6, ranging from 4 to 7 symptoms, in unvacci-
ated individuals and 2.5, ranging from 1 to 7 in vaccinated patients,
ith mild features. In relation to the features of the lesions, the vac-
inated individuals had an average of 2.5 injuries and unvaccinated
ndividuals had an average of 8 lesions. In relation to the place of
ccurrence of the lesions in vaccinated subjects they concentrated
argely on the hands (100%) and small events in other regions (17%)
nose, neck, and legs), while in unvaccinated individuals, the pri-
ary site of involvement was also on the hands (100%), but its
ccurrence in other regions was more signiﬁcant (40%). Analysis of
he days of leave of absence due to illness was 25% of the vaccinated
roup, which had an average of 10 days off, and in unvaccinated
ubjects an average of 15 days of sick leave for 60% of the individ-
als. There were two hospitalizations due to symptoms developed
fter treatment. There were no lethal cases. We  had reports that
amily members had also contracted the infection by VACV in both
roups analyzed.
.2. Natural cytotoxicity receptors (NCR) are expressed at higher
ercentages in individuals who had been previously exposed to
accinia virus
In order to evaluate NK cells phenotype, after in vitro stimula-
ion with UV-VACV, triple and fourth labeling were used. Initially
he cells were stained simultaneously against CD3, CD16 and
D56. The same cells were then labeled against NK cell recep-
ors, CD161, CD94, CD107a, NKp30, NKp44 and NKp46 to evaluate
he expression of these molecules in the NK cell surface. The
K cells phenotype was deﬁned based on the relative expression
f the CD16 (or FcRIIIA, low-afﬁnity receptor for the Fc portion
f immunoglobulin G) and CD56 (adhesion molecule mediating
omotypic adhesion) markers in ﬁve NK cell subpopulations: (1)
D56brightCD16− (50–70% of CD56bright), (2) CD56brightCD16dims conﬁrmed by visualization of a typical vaccination scar in their left arm and data
(30–50% of CD56bright), (3) CD56dimCD16−, (4) CD56dimCD16bright,
and (5) CD56−CD16bright (Cooper et al., 2001; Mavilio et al., 2005;
Caligiuri, 2008).
The results did not show any signiﬁcant difference in the mean
percentage of natural killer cells in the four groups, after in vitro
stimulation with UV-inactivated VACV when compared to control
cultures (Table 2). The analysis of NK cells subpopulations did not
show any signiﬁcant difference (data not shown).
Analysis of the expression of natural cytotoxicity receptors
NKp30, NKp44, and NKp46 showed a signiﬁcant increase in the
mean percentages of NK cells co-expressing NKp30 and NKp44
in the infected individuals (vaccinated and unvaccinated) and in
non-infected vaccinated subjects, when stimulated and control cul-
tures were compared (Fig. 1A–D). This was  not observed in the
non-infected unvaccinated group. Interestingly, the expression of
NKp44 receptor, was  lower in the non-infected unvaccinated group,
when stimulated and control cultures were compared (Fig. 1C). It
was also observed that NK cells co-expressing NKp30 or NKp44
were at higher percentages only in infected (vaccinated and unvac-
cinated) and in non-infected vaccinated patients, when compared
to non-infected unvaccinated subjects, after stimulation with UV-
inactivated VACV (Fig. 2A and B). However, our data showed that
expression of NKp46 by NK cells was  signiﬁcantly higher only in
the infected individuals (vaccinated and unvaccinated) when com-
pared control and stimulated cultures (Fig. 1E and F). Previously
infected subjects (vaccinated or not) had higher percentages of
NK cells co-expressing NKp46, when compared with non-infected
individuals (vaccinated or not) (Fig. 2C).
3.3. In vitro stimulation with UV-inactivated VACV upregulates
CD161 and downregulates the CD107a
In order to study the inhibitory receptors expressed by NK
cells, we analyzed CD161 molecule, which is one of the earliest
markers of NK cells (Di Santo, 2006), ﬁrstly designated as an acti-
vating receptor (Azzoni et al., 1998), however the expression of thisInfected Unvaccinated 26.72 ± 7.89
Vaccinated 30.79 ± 8.06
There were no statistically signiﬁcant differences in the mean percentage of NK cells
when the four groups were compared.
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Fig. 1. NCR’s evaluation of NK cells in the whole blood cells from individuals previously infected or not by zoonotic Vaccinia virus, before and after viral stimulation.
Whole  blood cells from patients infected or not with zoonotic Vaccinia virus were stimulated in the presence of UV-inactivated VACV or medium. The percentages of NK
cells  expressing Nkp30, Nkp44, Nkp46 and CD161 in control and stimulated cultures from infected and non-infected groups were evaluated by ﬂow cytometry. (A and B)
Percentage of Nkp30+ NK cells. (C and D) Percentage of Nkp44+ NK cells. (E and F) Percentage of Nkp46+ NK cells. (G and H) Percentage of CD161+ NK cells. The differences
between the groups are considered signiﬁcant at p less than 0.05 and are represented by * p, 0.05, ** p, 0.01 and *** p, 0.001.
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Fig. 2. NCR’s evaluation of NK cells in the whole blood cells from individuals previously infected or not by zoonotic Vaccinia virus, after viral stimulation. Whole blood cells
from  patients infected or not with zoonotic Vaccinia virus were stimulated in the presence of UV-inactivated VACV or medium. After stimulus, NK cells from infected and
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in infected (vaccinated and unvaccinated) and in non-infected vac-on-infected individuals were labeled with mouse anti-human Nkp30, Nkp44, Nkp4
kp44+ NK cells, after viral stimulation. (C) Percentage of Nkp46+ NK cells, after vir
etween the groups are considered signiﬁcant at p less than 0.05. (a) Different from
nd in non-infected vaccinated subjects, when control and stim-
lated cultures were compared. No signiﬁcant difference was
bserved in the non-infected unvaccinated group (Fig. 1G and H).
hen the four groups were compared after viral stimulation, our
ata showed that CD161 positive NK cells were at higher percent-
ges only in the groups that had previous contact with VACV, either
hrough vaccination or natural infection, when compared to non-
nfected unvaccinated subjects. Furthermore, previously infected
ndividuals (vaccinated and unvaccinated) had higher percentages
f this cells when compared to non-infected vaccinated subjects,
fter stimulation with UV-inactivated VACV (Fig. 2D).
Since the NK cells of the studied individuals were observed
o be activated as measured by NCRs staining, the degranulation
rocess was evaluated using the CD107a molecule. CD107a is a
egranulation marker of NK cell and its expression correlates with
oth cytokine secretion and NK cell-mediated lysis of target cells
Alter et al., 2004). Our results showed that CD107a expression
n the surface of NK cells was signiﬁcantly decreased in all four
roups studied, when control and stimulated cultures were com-
ared (Fig. 3A and B). No differences were observed between the
our groups, when stimulated cultures were compared (data not
hown).
.4. VACV induced a decrease in the expression of Granzyme A
nd Perforin by NK cells but did not affect the percentage of NK
ells co-expressing Granzyme B
Labeling of peripheral blood NK cells with antibodies against
ranzyme A, B, and Perforin was performed to evaluate the CD161. (A) Percentage of Nkp30+ NK cells, after viral stimulation. (B) Percentage of
ulation. (D) Percentage of CD161+ NK cells, after viral stimulation. The differences
infected unvaccinated. (b) Different from non-infected vaccinated.
process of cytotoxicity of natural killer cells. Expression of Per-
forin and Granzyme A by NK cells were signiﬁcantly lower when
control and stimulated cultures were compared in all four groups
(Fig. 3C–F). Our data did not show any signiﬁcant difference on
the percentage of NK cells co-expressing Perforin and Granzyme
A among the four groups when stimulated cultures were com-
pared (data not shown). A decrease in the percentage of NK cells
expressing Granzyme B in non-infected unvaccinated group was
observed when stimulated and control cultures were compared.
Nonetheless, the percentage of these cells was  higher in the
infected (vaccinated and unvaccinated) and in the non-infected
vaccinated individuals, when compared to noninfected unvacci-
nated group, after stimulation with UV-inactivated VACV (Fig. 3G
and H).
3.5. VACV stimulation upregulates CD94 expression
CD94 is another surface molecule involved in the development
and maturation of NK cells (Carretero et al., 1997; Lazetic et al.,
1996; Phillips et al., 1996). CD94 receptors have been proposed
to be important in NK cell tolerance to self, and contribute to NK
cell-mediated immunity to viral infections (Orr et al., 2010). In this
study, the mean percentage of CD94 positive NK cells were highercinated individuals, when control and stimulated cultures were
compared (Fig. 4A and B). No signiﬁcant difference between non-
infected and infected groups was observed after viral stimulation
(Fig. 4C).
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Fig. 3. Evaluation of the percentage of NK cells expressing CD107a, Perforin, Granzyme A and Granzyme B from infected and non-infected individuals, before and after
viral  stimulation. The percentages of CD107a+, Perforin+, Granzyme A+ and Granzyme B+ NK cells were evaluated by ﬂow cytometry. (A and B) CD107a+ NK cells. (C and D)
Perforin+ NK cells. (E and F) Granzyme A+ NK cells. (G and H) Granzyme B+ NK cells. The differences between the groups are considered signiﬁcant at p less than 0.05 and are
represented by * p, 0.05, ** p, 0.01 and *** p, 0.001.
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Fig. 4. Evaluation of NKCD94+ cells in the whole blood cells from individuals previously infected or not by zoonotic Vaccinia virus. Whole blood cells from patients infected
or  not with zoonotic Vaccinia virus were stimulated in the presence of UV-inactivated VACV or medium. After stimulus, NK cells were labeled with mouse anti-human
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cD94  antibody. (A and B) Percentage of NKCD94 in control and stimulated culture
on-infected groups, after viral stimulation. The differences between the groups ar
** p, 0.001. (a) Different from non-infected unvaccinated.
.6. Previous exposure to Vaccina virus leads to higher
ercentages of NK-TNF-  ˛ positive cells but not the number of
K-IFN- positive cells
Our results showed that the percentage of IFN-+ NK cells
as signiﬁcantly lower in the non-infected unvaccinated group,
hen control and stimulated cultures were compared (Fig. 5A and
). No signiﬁcant differences between non-infected and infected
roups were observed, when the stimulated cultures were com-
ared (Fig. 5E). Our data showed that the percentage of TNF-+ NK
ells was signiﬁcantly higher in infected (vaccinated and unvac-
inated) and in non-infected vaccinated individual, when control
nd stimulated cultures were compared (Fig. 5C and D). Analysis of
timulated cultures of the four groups demonstrated a higher per-
entage of TNF- positive NK cells only in the infected individuals
vaccinated and unvaccinated), when compared to non-infected
vaccinated and unvaccinated) subjects (Fig. 5F).
. Discussion
In the course of VACV infection, the activation, proliferation, and
ecruitment of NK cell at the site of infection has been shown to be
ecessary for virus clearance (Bukowski et al., 1983; Daniels et al.,
001; Dokun et al., 2001; Natuk and Welsh, 1987). Furthermore, NK
ells have long been proposed to mediate an important element infected and non-infected groups. (C) Percentage of NKCD94 from infected and
idered signiﬁcant at p less than 0.05 and are represented by * p, 0.05, ** p, 0.01 and
in the protective response against different Poxvirus (Bukowski
et al., 1983; Stitz et al., 1986). Previous work indicates that 6 h
are sufﬁcient for NK cells to be activated at the primary site of
infection (Prlic et al., 2005). These previous works had demon-
strated the importance of NK cells against VACV, using murine
models or individuals vaccinated against Smallpox. In this study
the phenotype of NK cells were described following a natural Vac-
cinia virus infection and compared with the proﬁle of NK cells
induced by smallpox vaccination. Thus, 22 previously infected indi-
viduals and 20 non-infected individuals were selected. Out of the
22 previously infected individuals, 12 were vaccinated against
smallpox and 10 were unvaccinated. From 20 non-infected indi-
viduals, 10 were vaccinated and 10 unvaccinated. It is interesting
to note that in the previously infected group, 12 individuals were
vaccinated against smallpox and despite their vaccination sta-
tus, they acquired the VACV infection, but developed a milder
form.
We demonstrated in a precedent work that previously infected
individuals (vaccinated or not) have higher percentages of T
memory cells when compared to non-infected individuals (both
vaccinated and unvaccinated). It was  also detected that just
the infected individuals (vaccinated and unvaccinated) presented
higher percentages of effector-memory T cells (TEM), capable to
produce IFN- and TNF-. In the non-infected individuals (vacci-
nated and unvaccinated), this increase in the mean percentage of T
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Fig. 5. Intracellular TNF- and IFN- detection in NK cells in the whole blood cells from individuals previously infected or not by zoonotic Vaccinia virus, before and after
viral  stimulation. Whole blood cells from patients infected or not with zoonotic Vaccinia virus were stimulated in the presence of UV-inactivated VACV or medium. The
percentages of NK cells expressing TNF- and IFN- in control and stimulated cultures from infected and non- infected groups were evaluated by ﬂow cytometry. (A and
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r)  Percentage of IFN-+ NK cells in control and stimulated cultures. (C and D) Perce
ells,  after viral stimulation. (F) Percentage of TNF-+ NK cells, after viral stimulatio
re  represented by * p, 0.05, ** p, 0.01 and *** p, 0.001. (a) Different from non-infecte
D4 memory lymphocytes expressing IFN- was not observed (Orr
t al., 2010).
In our studies, we also observed that recent infection by VACV
nduced a more signiﬁcant CD4 and CD8 effector memory response
hen we compared previously infected individuals (vaccinated
nd unvaccinated) to non-infected vaccinated patients (Orr et al.,
010). Once we demonstrated that CD4 and CD8 T cells were
nvolved in the immune memory response following a natural
nfection with Vaccinia virus, we developed this work since it is
ell known that both the innate and adaptative responses are
mportant to clear the infection (Lewis-Jones, 2004). We  aimed to
escribe the phenotype of NK cells in the whole blood cells from
reviously infected and non-infected individuals, to better under-
tand the human immunological response against VACV natural
nfection.
It is well known that different receptor–ligand interactions are
esponsible for NK-cell activation upon interaction with target cells. of TNF-+ NK cells in control and stimulated cultures. (E) Percentage of IFN-+ NK
e differences between the groups are considered signiﬁcant at p less than 0.05 and
accinated.
In this study, we determined the proﬁle of activation, degranula-
tion and inhibition of NK cells following a natural Vaccinia virus
infection and compared it to NK cells phenotype of non-infected
individuals, previously vaccinated or not against smallpox. It has
been described that natural cytotoxic receptors (NCRs) are involved
in NK-cell activation upon interaction with target cells. In our work,
we demonstrated an increase in the expression of these natu-
ral cytotoxic receptors (NCRs) NKp30, NKp44 and NKp46 by NK
cells, after viral stimulation, only in individuals that were previ-
ous exposed to VACV, either by vaccination against smallpox or
recent natural infection. Our data also showed that the percent-
age of NK cells expressing NKp44 was  lower in the non-infected
unvaccinated individuals, when control and stimulated cultures
were compared. A signiﬁcant increase on the percentage of NK
cells expressing NKp46 were observed when we compared con-
trol and stimulated cultures of infected individuals (vaccinated and
unvaccinated), but not in the non-infected groups (vaccinated and
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nvaccinated). When we analyzed the stimulated cultures of the
our groups, we observed higher percentages of Nkp46+ cells in
reviously infected individuals compared with non-infected sub-
ects (vaccinated or not). We  also observed a higher percentage
f Nkp46+ cells in non-infected vaccinated individuals compared
o non-infected unvaccinated patients. Our data suggest that NCRs
re involved in VACV recognition after a previous exposure to anti-
en and probably participate in the immune response to clear the
nfection. A precedent work demonstrated that pre-treatment of
K cells with a cocktail of MAbs speciﬁc for all three NCRs com-
letely blocked NK recognition of VACV-infected cells (Chisholm
nd Reyburn, 2006). This demonstrates the importance of NCR’s in
iral recognition and clearance.
Another surface marker analyzed in this work was  the CD94
olecule. Our data demonstrated an increase on the percentage
f NK cells expressing this marker in the infected (vaccinated
nd unvaccinated) and non-infected vaccinated individuals, when
ompared with non-infected unvaccinated subjects, after viral
timulation. Previous work with murine models demonstrated that
D94 has an essential role in resistance of infected mice with
ctromelia virus (Fang et al., 2008, 2010, 2011). So, we can spec-
late that the up regulation of this molecule detected in our work
s probably associated with the resistance against Vaccinia virus as
t has been demonstrated in previous works with Ectromelia virus
Fang et al., 2008, 2010, 2011). However, our data showed that
nly infected (vaccinated and unvaccinated) and non-infected vac-
inated individuals, had higher percentages of NK cells expressing
D94, when compared with non-infected unvaccinated subjects,
fter viral stimulation, suggesting that previous exposure may
ffect the expression of this markers by NK cells leading to faster
limination of the virus.
The ﬁnding of higher percentages of NK cells expressing
CR’s (Nkp30, Nkp44 and Nkp46) suggests it is important role
n these cells. However, it is also known that the degranula-
ion and secretion processes of NK cells may  also be inhibited
fter viral stimulation. Therefore, in order to determine whether
nhibition of degranulation was occurring, we NK cells were intra-
ellular staining for Perforin, Granzyme A and B and CD107a.
ur results showed that after in vitro stimulation with Vaccinia
irus the percentages of Perforin+, Granzyme A+ and CD107a+ NK
ells were lower, in previously infected (vaccinated and unvacci-
ated) and non-infected vaccinated individuals, when compared
o non-infected unvaccinated subjects. Moreover, VACV induced
n increase in the percentage of NK cells expressing CD161, an
nhibitory molecule (Rosen et al., 2005; Aldemir et al., 2005), and
ranzyme B, in these same groups of individuals. This was not
bserved in non-infected unvaccinated individuals. This downreg-
lation of molecules that are involved in the degranulation and
ecretion processes associated with the upregulation of CD161,
n inhibitory molecule, found in our work, could lead to an
mpaired NK cell immune response against Vaccinia virus, in
hese individuals, but the mechanisms of this process must be
tudied.
Experiments in murine models suggested that Perforin-
ediated cytolysis was not required for resistance to VACV,
esicular stomatitis virus, or Semiliki Forest virus (Kagi et al., 1995).
urthermore, mice of the highly EV-resistant C57BL/6 background
ave an increased loss of resistance to EV when mutant mice deﬁ-
ient in GrA, GrB, or GrA and GrB were evaluated (Mullbacher et al.,
999). These studies demonstrated that mice lacking Perforin or
ranzymes were unable to control primary EV infection and sug-
ested an important role for these serine proteases in resistance
o poxviruses. Our results do not show similar data but they sug-
est that in human infection the balance between Perforin and
ranzymes is necessary for the immune response against VACV
nfection.Research 184 (2014) 20–29
We  also evaluated the expression of intracellular cytokines
by NK cells and the data showed that the percentage of IFN-
+ NK cells was  signiﬁcantly lower in non-infected unvaccinated
group when control and stimulated cultures were compared. We
observed that infected (vaccinated and unvaccinated) and non-
infected vaccinated subjects had higher percentages of IFN-+ NK
cells when compared with the non-infected unvaccinated individ-
uals, after viral stimulation. The importance of IFN- in host defense
against VACV is well established (Reading and Smith, 2003). Pre-
vious studies with CD4 memory T cells demonstrated that VACV
infection induces the production of IFN- and that the frequency
of IFN- producing cell is higher in previously vaccinated vol-
unteers when compared with unvaccinated healthy volunteers
(Combadiere et al., 2004; Puissant-Lubrano et al., 2010). Our data
also demonstrated a higher percentage of NK cells expressing IFN-
 by groups that have been previous exposed to VACV. Analysis
of TNF-+ NK cells demonstrated a higher percentage of these
cells in infected (vaccinated and unvaccinated) and non-infected
vaccinated individuals, when compared to non-infected unvacci-
nated, after in vitro stimulation with UV-inactivated VACV. The
role of TNF- in protection against VAVC infection has been previ-
ously explored and it was  demonstrated that Smallpox vaccination
induces TNF- expression by CD4+ memory T cells (Puissant-
Lubrano et al., 2010; Hammarlund et al., 2003, 2010). Although our
work analyzed the TNF-+ NK cells population it is important to
notice that this population is signiﬁcantly increased in those indi-
viduals who had a history of VACV infection or smallpox vaccination
but not in non-infected unvaccinated subjects. Our results showed
that NK cells are also an important source of TNF-, a cytokine
involved in the mechanisms of viral clearance.
In this work NK cells phenotype from individuals previously
infected with VACV (vaccinated and unvaccinated) following a nat-
ural VACV infection was described and compared with the proﬁle of
NK cells induced by smallpox vaccination (non-infected vaccinated
individuals). A negative control using non-infected unvaccinated
individuals was  used to compare the data presented by infected
(vaccinated and unvaccinated) and non-infected vaccinated sub-
jects. In this study we  did not observe any difference in NK cells
phenotype when we  compared infected (vaccinated and unvac-
cinated) individuals to non-infected vaccinated patients (except
with marker NKp46). However, we  observed signiﬁcant differences
when comparing infected (vaccinated and unvaccinated) and non-
infected vaccinated individuals to the unvaccinated non-infected
group, after stimulation with UV-inactivated VACV.
It seems that previous exposure to VACV (either by infection or
vaccination) leads to a more robust NK cell immune response in
a second Ag exposure, since we demonstrated that NK cells from
previously infected individuals (vaccinated and unvaccinated) and
non-infected vaccinated subjects expressed higher percentages of
NCRs (NKp 30, 44 and 46), Granzyme B, INF- and TNF- (molecules
involved in lysis of target cells) when compared to non-infected
unvaccinated individuals, after stimulation with UV-inactivated
VACV.
In addition, our data showed that previous exposure to the anti-
gen (either by natural infection or vaccination) induced partial
protection that leads to a milder form of VACV infection, demon-
strated by our clinical data. In previous work of our group we
suggested that this fact occurred due to the long time interval
between Vaccinia virus infection and vaccination, at least 30 years
before the recent infection. So, previous exposure to the antigen
induced partial protection that was  reﬂected on a milder symptoms
(Medeiros-Silva et al., 2013). Corroborating with the data presented
in this work, previous studies with human Monkeypox infection
indicated that smallpox vaccination was  not able to prevent the
infection, but it seems that Monkeypox infection in humans that
received a smallpox vaccine manifested in a milder form (Heymann
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t al., 1998). Another study also suggests that receipt of smallpox
accination more than 3–4 decades ago may  not provide current
rotection. Furthermore, this study demonstrated that, vaccinia-
peciﬁc CD4+ and CD8+ T cell responses obviously decline with age
Hsieh et al., 2004). In our work, the vaccinated groups are sig-
iﬁcantly older than the control group and this could interfere in
he NK cells responses, although we did not detect any signiﬁcant
ifference when we compared the previously vaccinated individ-
als (infected and non-infected) with the unvaccinated infected
ubjects. We  had demonstrated that there were some signiﬁcant
ifferences in the phenotype of NK cells when we compared the
nfected (vaccinated and unvaccinated) and non-infected vacci-
ated individuals with the unvaccinated non-infected subjects.
owever we can speculate that this difference is not just due to
he age of the individuals, but it is also associated with the previ-
us exposure to the VACV. Our hypothesis is reinforced by another
tudy that showed that a proliferative memory responses to VACV
ersisted in 72% of the population and were not inﬂuenced by age
Combadiere et al., 2004). We  suggest that previous exposure to
ACV, either by recent infection or smallpox vaccination, leads to
 more robust immune response mediated by NK and T memory
ells, as we previously described (Medeiros-Silva et al., 2013), but
t this moment we cannot identify what mechanisms are involved
n this process.
It is necessary to further explore the mechanisms involved in the
ctivation, degranulation and inhibition of NK cells to fully eluci-
ate the roles of the distinct aspects of the immune response against
 primary and secondary response to VACV infection.
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